GB1090754A - Improvements relating to immunising materials - Google Patents

Improvements relating to immunising materials

Info

Publication number
GB1090754A
GB1090754A GB30615/63A GB3061563A GB1090754A GB 1090754 A GB1090754 A GB 1090754A GB 30615/63 A GB30615/63 A GB 30615/63A GB 3061563 A GB3061563 A GB 3061563A GB 1090754 A GB1090754 A GB 1090754A
Authority
GB
United Kingdom
Prior art keywords
strain
horses
mice
escherichia coli
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB30615/63A
Other languages
English (en)
Inventor
John Cameron
John Scarnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE651300D priority Critical patent/BE651300A/xx
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB30615/63A priority patent/GB1090754A/en
Priority to IL21785A priority patent/IL21785A/xx
Priority to NL6408788A priority patent/NL6408788A/xx
Priority to LU46667D priority patent/LU46667A1/xx
Priority to BR161321/64A priority patent/BR6461321D0/pt
Priority to AT659164A priority patent/AT259133B/de
Priority to FR1561053D priority patent/FR1561053A/fr
Priority to CH1006664A priority patent/CH484276A/de
Priority to DK380064AA priority patent/DK113945B/da
Priority to ES0302685A priority patent/ES302685A1/es
Priority to SE09377/64A priority patent/SE328371B/xx
Publication of GB1090754A publication Critical patent/GB1090754A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB30615/63A 1963-08-01 1963-08-01 Improvements relating to immunising materials Expired GB1090754A (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
BE651300D BE651300A (xx) 1963-08-01
GB30615/63A GB1090754A (en) 1963-08-01 1963-08-01 Improvements relating to immunising materials
IL21785A IL21785A (en) 1963-08-01 1964-07-28 Immunising materials derived from a new strain of escherichia coli
BR161321/64A BR6461321D0 (pt) 1963-08-01 1964-07-31 Aperfeicoamento em processo para a producao de uma vacina para a prevencao ou tratamento de infeccoes por escherichia coli
LU46667D LU46667A1 (xx) 1963-08-01 1964-07-31
NL6408788A NL6408788A (xx) 1963-08-01 1964-07-31
AT659164A AT259133B (de) 1963-08-01 1964-07-31 Verfahren zur Herstellung von aktiv oder passiv immunisierendem Material gegen Escherichia coli-Infektionen
FR1561053D FR1561053A (xx) 1963-08-01 1964-07-31
CH1006664A CH484276A (de) 1963-08-01 1964-07-31 Verfahren zur Gewinnung eines Materials, welches zur Herstellung eines Impfstoffes zur Verhütung oder Behandlung von Escherichia-coli-Infektionen geeignet ist
DK380064AA DK113945B (da) 1963-08-01 1964-07-31 Fremgangsmåde til fremstilling af et middel til forebyggelse eller behandling af Escherichia coli-infektioner.
ES0302685A ES302685A1 (es) 1963-08-01 1964-07-31 Un metodo para cultivar una cepa de escherichia coli.
SE09377/64A SE328371B (xx) 1963-08-01 1964-08-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB30615/63A GB1090754A (en) 1963-08-01 1963-08-01 Improvements relating to immunising materials

Publications (1)

Publication Number Publication Date
GB1090754A true GB1090754A (en) 1967-11-15

Family

ID=10310436

Family Applications (1)

Application Number Title Priority Date Filing Date
GB30615/63A Expired GB1090754A (en) 1963-08-01 1963-08-01 Improvements relating to immunising materials

Country Status (12)

Country Link
AT (1) AT259133B (xx)
BE (1) BE651300A (xx)
BR (1) BR6461321D0 (xx)
CH (1) CH484276A (xx)
DK (1) DK113945B (xx)
ES (1) ES302685A1 (xx)
FR (1) FR1561053A (xx)
GB (1) GB1090754A (xx)
IL (1) IL21785A (xx)
LU (1) LU46667A1 (xx)
NL (1) NL6408788A (xx)
SE (1) SE328371B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae

Also Published As

Publication number Publication date
NL6408788A (xx) 1965-02-02
CH484276A (de) 1970-01-15
AT259133B (de) 1967-12-27
DK113945B (da) 1969-05-12
SE328371B (xx) 1970-09-14
IL21785A (en) 1968-05-30
LU46667A1 (xx) 1965-02-01
BE651300A (xx) 1900-01-01
BR6461321D0 (pt) 1973-09-20
ES302685A1 (es) 1965-05-16
FR1561053A (xx) 1969-03-28

Similar Documents

Publication Publication Date Title
Rowley The virulence of strains of Bacterium coli for mice
Dubos et al. The effect of a tissue enzyme upon pneumococci
Wentz et al. Clostridium botulinum type F: seasonal inhibition by Bacillus licheniformis
GB1090754A (en) Improvements relating to immunising materials
Cole et al. The production of antipneumococcic serum
Dawson The transformation of pneumococcal types: I. the conversion of r forms of pneumococcus into s forms of the homologous type
Maitland et al. Experiments on the cultivation of vaccinia virus
Roberts Toxic, allergenic and immunogenic factors of Fusiformis necrophorus
Roberts et al. Pertussis toxin
Weiss Observations on Bacterium melaninogenicum: Demonstration of Fibrinolysin, Pathogenicity and Serological Types.
Teale Some Observations on the Relative Importance of the Reticulo-Endothelial Tissues and the Circulating Antibody in Immunity: I. Bacterial Immunity in Relation to the Rôle Played by the Circulating Antibody and the Tissues Following Intravenous Introduction of the Bacteria
US3793150A (en) Equine strangles vaccine and method of preparing and using the same
Li STUDIES ON THE DISSOCIATION OF THE HOG CHOLERA BACILLUS: III. ACTIVE IMMUNIZATION WITH R FORMS
Gledhill et al. The toxicity of some bacterial filtrates for mice pre-infected with Eperythrozöon coccoides
Fisher Experimental Staphylococcal Infection of the Subcutaneous Tissue of the Mouse: II. Promotion of the Infection with Staphylococcal Cells and Products
Ospeck et al. Pertussis antitoxin: its relationship to protection in actively and passively immunized mice and rabbits
Cortiñas et al. Alpha-Toxin Production byClostridium septicumat Different Culture Conditions
Dulaney Microbic dissociation of B. coli-communis
Yamamoto et al. Production of, and susceptibility to, bacteriocin-like substances in oral streptococci
Dubos The effect of the bacteriolytic enzyme of pneumococcus upon the antigenicity of encapsulated pneumococci
Murray A Note on the Stability of the Gravis, Mitis, and Intermediate Types of C. diphtheriæ
Henderson Studies on Clostridium chauvœi. II: Active Immunization with Pure “O” Antigen
Clark et al. A filtrable toxic product of the hemolytic streptococcus
Chadwick Effects of immunization on the LD50 of two pathogens of Galleria mellonella
Gunnison Agglutination reactions of the heat stable antigens of Clostridium tetani